NCT02521688

Brief Summary

Investigators have shown the presence of elevated proinflammatory cytokines in amniotic fluid in patients in preterm labor.However, there is limited and mostly negative evidence that the elevation of these mediators in gingival crevicular fluid (GCF), and amniotic fluid are associated with pregnancy complications in periodontitis patients. Thus this case control study will be conducted to

  1. 1.To determine the level of proinflammatory cytokines in gingival crevicular fluid in women with spontaneous preterm delivery with chronic periodontitis.
  2. 2.To investigate the expression of macrophage inflammatory protein-1α in placental tissues.
  3. 3.To assess the possible correlation between chronic periodontitis and preterm delivery.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2013

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 11, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2015

Completed
Last Updated

August 13, 2015

Status Verified

August 1, 2015

Enrollment Period

1.9 years

First QC Date

August 11, 2015

Last Update Submit

August 11, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Proinflammatory cytokine level

    MIP, TNF, Pentrixin 3 measured in placental tissue homogenate and in GCF

    1 year

Study Arms (4)

Group I (PTD + CP)

include ten mothers exhibiting spontaneous preterm delivery with moderate to severe chronic periodontitis +incisional biopsy from placenta and GCF sample

Procedure: incisional biopsy from placenta and GCF sample

Group II (TD + CP)

include ten mothers exhibiting spontaneous term delivery with moderate to severe chronic periodontitis+incisional biopsy from placenta and GCF sample

Procedure: incisional biopsy from placenta and GCF sample

Group III (PTD + HP)

include tenmothersexhibiting spontaneous preterm delivery with healthy periodontium +incisional biopsy from placenta and GCF sample

Procedure: incisional biopsy from placenta and GCF sample

Group IV (TD + HP)

ten mothersexhibiting spontaneous term delivery with healthy periodontium(Armitage GC. 1999)+ incisional biopsy from placenta and GCF sample

Procedure: incisional biopsy from placenta and GCF sample

Interventions

A small piece of villous placental tissue (approximately 1 cm3) will be dissected free of maternal decidua from the placental bed after delivery of fetus processed to prepare tissue homogenate according to the standardized technique (Keelan JA, et al. 1999) GCF will be obtained from each patient by filter paper inserted in gingival crevice for few seconds after isolation by cotton.

Group I (PTD + CP)Group II (TD + CP)Group III (PTD + HP)Group IV (TD + HP)

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Fourty Mothers participating in this study recruited from Maternal-Fetal medicine clinic, Faculty of Medicine, Ain Shams University that must undergo delivery without induction, i.e. delivery following labour pains not pre-scheduled caesarian sections

You may qualify if:

  • Undergoing spontaneous term delivery (TD) at ≥37 weeks of gestation without any obstetrical or medical complications or spontaneous preterm delivery (PTD)at\< 37 weeks of gestation after uterine contraction or rupture of membranes(Keelan JA, et al. 1999).
  • With a body mass index (BMI) ranged from 19-25.
  • Having no systemic disease as evidenced by Burkett's oral medicine health history questionnaire (Glick et al, 2008).

You may not qualify if:

  • Mothers receiving antibiotics or corticosteroids during last three months of pregnancy or at delivery.
  • Current Smokers and drug abusers or stopped from period shorter than 6 months.
  • Mothers with urinary tract infection, vulvovaginal infection, previous preterm birth, or any othermedical disorder associated with pregnancy as obtained from patient's record.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Placental tissue Gingival clevicular fluid from deepest pocket

MeSH Terms

Conditions

Obstetric Labor, PrematurePeriodontitis

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of oral medicine and periodontology

Study Record Dates

First Submitted

August 11, 2015

First Posted

August 13, 2015

Study Start

August 1, 2013

Primary Completion

July 1, 2015

Study Completion

August 1, 2015

Last Updated

August 13, 2015

Record last verified: 2015-08